Vote for New FDA Commissioner: Let Obama Know

Who Should Obama Nominate for FDA Commissioner?

It seems like everyone in the Pharma Blogosphere and the press is recommending who president-elect Barack Obama should nominate -- when he becomes president -- as the new FDA Commissioner to replace Dr. Andrew von Eschenbach (see here for comments from the pundits and press).

The following list presents the major contenders the pundits have identified.

* Robert Califf, vice chancellor for clinical research and professor of medicine in the Division of Cardiology at Duke.
* Dora Hughes, Health Policy Advisor to Senator Barack Obama.
* David Kessler, former FDA Commissioner.
* Steve Nissen, cardiologist at Cleveland Clinic.
* Mary Pendergast, industry consultant who was a former associate FDA Commissioner under David Kessler.
* Peter Rost, former Pfizer VP of Marketing, now a blogger.
* Joshua Sharfstein, commissioner of the Baltimore City Health Department.
* Mike Taylor, former Deputy FDA Commissioner under Clinton
* Susan Wood, the former head of women’s health at FDA, who resigned in protest after the delay in switching the morning-after pill over-the-counter.
* Janet Woodcock, Center for Drug Evaluation & Research Director

Please take a few minutes to tell me who you think President-elect Obama should nominate as the new FDA Commissioner. If you don't like any of these choices, you can write-in your own candidate!

Take the survey here.

You can learn more about the contenders mentioned above when you access the survey site. After completing the survey, you will be able to see a summary of the results (de-identified to protect respondents anonymity).

Results of this survey may be summarized in Pharma Marketing News.

Your comments are confidential (anonymous) unless you specifically provide your contact information at the end of the survey and allow us to attribute comments to you personally.

See the Pharma Marketing Surveys Forum and the post "SURVEY: Who Should be FDA Commissioner?" for news and opinions about who the new FDA commissioner should be.